KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Assets: 2010-2025

Historic Return on Assets for Regeneron Pharmaceuticals (REGN) over the last 15 years, with Sep 2025 value amounting to 0.12%.

  • Regeneron Pharmaceuticals' Return on Assets fell 1.00% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of 0.12% for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Regeneron Pharmaceuticals' Return on Assets is 0.12%, which was down 0.76% from 0.12% recorded in Q2 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Return on Assets ranged from a high of 0.33% in Q4 2021 and a low of 0.11% during Q1 2024.
  • Over the past 3 years, Regeneron Pharmaceuticals' median Return on Assets value was 0.12% (recorded in 2023), while the average stood at 0.12%.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Return on Assets climbed by 12bps in 2021 and then fell by 18bps in 2022.
  • Regeneron Pharmaceuticals' Return on Assets (Quarterly) stood at 0.33% in 2021, then decreased by 18bps to 0.15% in 2022, then declined by 3bps to 0.12% in 2023, then remained steady at 0.12% in 2024, then decreased by 1bps to 0.12% in 2025.
  • Its Return on Assets stands at 0.12% for Q3 2025, versus 0.12% for Q2 2025 and 0.12% for Q1 2025.